Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Philippe Mueller has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 28, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13153246

Organic compounds

IPC classification:
A61K 31/4427, A61K 31/4965, A61K 31/497, A61P 37/06, A61P 37/08, C07D 213/73, C07D 241/20, C07D 401/06, C07D 401/14
Applicant:
Novartis AG
Agent:
Philippe Mueller, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11757864

PYRAZINE DERIVATIVES AS ENAC BLOCKERS

IPC classification:
A61K 31/497, A61P 11/00, C07D 241/26, C07D 403/12, C07D 487/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11757294

TRIAZINE-OXADIAZOLES

IPC classification:
A61K 31/53, A61P 29/00, C07D 413/04, C07D 413/14, C07D 417/14, C07D 451/02, C07D 487/04, C07D 491/10, C07D 498/08
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature